Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 125 of 201 entries
View as:

Venous Thromboembolism in Advanced Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03581708 Org: User:
Start: 07/31/18 End: 06/30/22 Due: 06/30/23

The Impact of Genotype on Pharmacokinetics and Antiplatelet Effects of Ticagrelor in Healthy Chinese

Phase: N/A Priority: Normal
NCT ID: NCT03092076 Org: User:
Start: 05/20/15 End: 06/16/16 Due: 06/16/17

Treatment Free Remission (TFR) in CML Patients （CML-CP）Study

Phase: N/A Priority: Normal
NCT ID: NCT05440747 Org: User:
Start: 07/31/22 End: 10/31/31 Due: 10/31/32

A New Application of Amiloride in the Treatment of Patient With Chronic Kidney Disease In Reducing Urinary PROtein

Phase: N/A Priority: Normal
NCT ID: NCT03170336 Org: User:
Start: 03/01/18 End: 08/01/20 Due: 08/01/21

PARPi or Capecitabine Combined With PD-1 Inhibitors as Adjuvant Therapy in High-risk TNBC

Phase: N/A Priority: Normal
NCT ID: NCT06533384 Org: User:
Start: 08/01/24 End: 12/31/30 Due: 12/31/31

Magnetic Field Modulation Pillow for Insomnia Clinical Trial

Phase: N/A Priority: Normal
NCT ID: NCT03397472 Org: User:
Start: 01/18/18 End: 12/30/19 Due: 12/30/20

The Effect of Preserving Inferior Pulmonary Ligamen on Symptom Burden in Thoracoscopic Pneumonectomy

Phase: N/A Priority: Normal
NCT ID: NCT06452680 Org: User:
Start: 06/30/24 End: 08/31/24 Due: 08/31/25

Monitoring Skeletal Muscle Mass Using CBCT in Patients With H&N Cancer Undergoing Chemoradiotherapy

Phase: N/A Priority: Normal
NCT ID: NCT05126095 Org: User:
Start: 11/03/21 End: 03/30/23 Due: 03/30/24

Evaluate Efficacy and Safety of XELOX in Potentially Resectable Liver Metastasis From Colorectal Cancer(CRC)

Phase: N/A Priority: Normal
NCT ID: NCT00997685 Org: User:
Start: 11/30/09 End: 10/31/15 Due: 10/31/16

Predictive Value of Non-fasting Blood Lipid Levels for Cardiovascular Events in Community Population(PICC Study)

Phase: N/A Priority: Normal
NCT ID: NCT04212520 Org: User:
Start: 01/01/20 End: 12/31/50 Due: 12/31/51

Letrozole Plus Low-Dose Metronomic Capecitabine Versus EC-T (Epirubicin/Cyclophosphamide Followed by Docetaxel) as Neoadjuvant Therapy for ER+/HER2-negative Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03507465 Org: User:
Start: 11/29/17 End: 11/29/20 Due: 11/29/21

Study of Hemodynamics of Neonates by Echocardiography and USCOM

Phase: N/A Priority: Normal
NCT ID: NCT01045252 Org: User:
Start: 10/31/08 End: 12/31/11 Due: 12/31/12

Neoadjuvant Almonertinib Followed by Chemo-immunotherapy in II-IIIB EGFR-mutant NSCLC

Phase: N/A Priority: Normal
NCT ID: NCT06300424 Org: User:
Start: 04/30/24 End: 09/30/27 Due: 09/30/28

Tacrolimus Combined With Entecavir on HBV Associated Glomerulonephritis(HBV-GN)

Phase: N/A Priority: Normal
NCT ID: NCT03062813 Org: User:
Start: 02/01/17 End: 03/31/20 Due: 03/31/21

A Phase II Single-Arm Clinical Study to Explore the Efficacy and Safety of Hyperbaric Oxygen in the Neoadjuvant Treatment of Breast Cancer Patients

Phase: N/A Priority: Normal
NCT ID: NCT06811870 Org: User:
Start: 02/01/25 End: 12/31/26 Due: 12/31/27

Safety and Efficacy Study of Allogenic Mesenchymal Stem Cells to Treat Extensive Chronic Graft Versus Host Disease

Phase: N/A Priority: Normal
NCT ID: NCT00972660 Org: User:
Start: 09/30/09 End: 12/31/17 Due: 12/31/18

Continuous Heparin Infusion to Prevent Catheter-related Thrombosis

Phase: N/A Priority: Normal
NCT ID: NCT04767113 Org: User:
Start: 03/01/21 End: 08/31/22 Due: 08/31/23

Targeted Treatment With Intercalated Radiotherapy in EGFR-mutant IIIA/IIIB NSCLC

Phase: N/A Priority: Normal
NCT ID: NCT03074864 Org: User:
Start: 02/27/17 End: 06/30/20 Due: 06/30/21

Effect of Mental Stress on Myocardial Perfusion in Women

Phase: N/A Priority: Normal
NCT ID: NCT03982901 Org: User:
Start: 06/18/19 End: 04/29/21 Due: 04/29/22

Intervention for High-normal Blood Pressure in Adults With Type 2 Diabetes-----renal Substudy

Phase: N/A Priority: Normal
NCT ID: NCT04978649 Org: User:
Start: 09/01/21 End: 07/31/28 Due: 07/31/29

Chidamide for Refractory/Relapsed Peripheral T Cell Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT02944812 Org: User:
Start: 03/31/16 End: 01/31/19 Due: 01/31/20

Probucol Combined With Valsartan in Reducing Proteinuria in Diabetes Nephropathy

Phase: N/A Priority: Normal
NCT ID: NCT00655330 Org: User:
Start: 05/31/08 End: 05/31/17 Due: 05/31/18

A Nomogram for Predicting the Diagnosis of Central Malignant Tumors Based on Preoperative Clinical Characteristics and Laboratory Indicators:

Phase: N/A Priority: Normal
NCT ID: NCT06914700 Org: User:
Start: 09/01/16 End: 12/01/24 Due: 12/01/25

EndovaScular Versus mediCaL mAnagement of Uncomplicated Type B Intramural heMatoma Trial (ESCLAIM)

Phase: N/A Priority: Normal
NCT ID: NCT04808661 Org: User:
Start: 03/01/21 End: 03/01/24 Due: 03/01/25

PreOperative Methylprednisolone on Thoracic Endovascular Repair for Reducing Post-implantation Syndrome (POMTEVAR)

Phase: N/A Priority: Normal
NCT ID: NCT05349071 Org: User:
Start: 05/01/22 End: 10/01/24 Due: 10/01/25